1.Prevalence of Hepatitis B Virus and HIV Co-infection in Korea.
Hyun Ho LEE ; Hae Guen HONG ; Jong Seong SON ; Sun Mok KWON ; Bu Geon LIM ; Kang Bum LEE ; Gu Hwan KIM
Journal of Bacteriology and Virology 2016;46(4):283-287
Hepatitis B virus (HBV) and human immunodeficiency virus (HIV) have a common route like sexually transmitted infections (STIs), vertical transmission and blood transfusion, etc. Therefore, it was necessary to be an attempt to confirm the relationship of HBV and HIV in Korea. We investigated the prevalence of Hepatitis B surface antigen (HBsAg) and Hepatitis B core antibody (anti-HBc) in HIV positive groups (n=430) and HIV negative groups (n=434) from January 2014 to October 2015. When comparing the prevalence of anti-HBc between the two groups, HIV positive group (36.0%) showed a higher prevalence than HIV negative group (24.7%), the result was statistically significant (p < 0.05). However, there was a little difference on HBsAg and not significant. Therefore, by showing a clear difference in anti-HBc between the two groups of HIV in Korea, it was confirmed to be associated with co-infections between Hepatitis B and HIV.
Blood Transfusion
;
Coinfection*
;
Hepatitis B Surface Antigens
;
Hepatitis B virus*
;
Hepatitis B*
;
Hepatitis*
;
HIV*
;
Korea*
;
Prevalence*
;
Sexually Transmitted Diseases
2.Effect of Metformin Treatment and Insulin Resistance in Patients with Polycystic Ovary Syndrome.
Kyu Ri HWANG ; Young Min CHOI ; Doo Seok CHOI ; Kwang Hyun BAEK ; Hye Won JEON ; Kwang Bum BAE ; Young Soo SON ; Seung Yup KU ; Byung Chul JEE ; Chang Suk SUH ; Seok Hyun KIM ; Jung Gu KIM ; Shin Yong MOON
Korean Journal of Obstetrics and Gynecology 2004;47(10):1949-1953
OBJECTIVE: This study was performed to investigate the effect of metformin treatment and insulin resistance in the patients with polycystic ovary syndrome. METHODS: Twenty three patients with polycystic ovary syndrome were included at Seoul National University Hospital from September 2001 to September 2003. Metformin was administered at daily 1,500 mg for 3 months to these patients. Then restoration of regular menstruation or recovery of ovulation was evaluated and insulin resistance was compared between the responder and the non-responder before and after metformin treatment. RESULTS: Eleven patients (47.8%) showed a significant improvement in menstrual or ovulation cyclicity whereas twelve patients had no change. There was no statistically significant difference in the insulin resistance between the responder and the non-responder before and after metformin treatment. CONCLUSION: In non-obese patients with polycystic ovary syndrome, metformin treatment seems to be effective to improvement of menstrual or ovulation cyclicity irrespective of insulin resistance expressed as glucose-to- insulin ratio and HOMA.
Female
;
Humans
;
Insulin Resistance*
;
Insulin*
;
Menstruation
;
Metformin*
;
Ovulation
;
Periodicity
;
Polycystic Ovary Syndrome*
;
Seoul
3.Two Small Intravenous Catheters for High-Rate Contrast Medium Injection for Computed Tomography in Patients Lacking Superficial Veins to Accommodate a Large Catheter.
Bum Gu SON ; Min Jung KIM ; Myeung Hwa PARK ; Kyoungsook KIM ; Jiyu KIM ; Se Young KIM ; Kyung Jin LEE ; Sang Hyun CHOI ; Ah Young KIM ; Seong Ho PARK
Korean Journal of Radiology 2018;19(3):489-497
OBJECTIVE: To prospectively investigate the feasibility of using 2 small intravenous catheters for high-rate computed tomography (CT) contrast injection in patients lacking superficial veins capable of accommodating ≤ 20-gauge catheters. MATERIALS AND METHODS: Sixty-eight consecutive eligible adults referred for dynamic liver CT were enrolled; 58 had previously undergone liver CT, including 8 that experienced extravasation. Two 22- or 24-gauge catheters were placed in all patients after 2–5 venipunctures, and 2 mL/kg of contrast agent (370 mg I/mL) was split-administered through both catheters to achieve total flow rate of 4 mL/s. Patients' experience and examination success rate, defined as uneventful scans completed at 4 mL/s or at < 4 mL/s achieving standard image quality in all phases, were analyzed. Quantitative hepatic signal-to-noise and hepatic vascular contrast-to-noise ratios (CNRs) were compared with 30 control examinations scanned at 4 mL/s using an 18-gauge catheter. RESULTS: One case each of extravasation and severe injection pain caused the examination to be aborted. Success rate was 88.2% (60/68; 54 patients scanned at 4 mL/s, 6 at 3.5–3.9 mL/s). Fifty-five of 58 patients (94.8%) that had past CT regarded the venipuncture as more tolerable than (n = 36) or similar to (n = 19) past experiences; 45 of 58 patients (77.6%) found contrast injection less painful than (n = 35) or similar to (n = 10) past experiences. When compared with control examinations, signal-to-noise ratio was similar in all phases (p ≥ 0.502), but the hepatic arterial CNR in arterial phase was slightly inferior (p ≤ 0.047). CONCLUSION: Using 2 small intravenous catheters can effectively achieve high-rate CT contrast injection in patients lacking adequate superficial veins.
Adult
;
Catheters*
;
Contrast Media
;
Humans
;
Liver
;
Multidetector Computed Tomography
;
Patient Satisfaction
;
Phlebotomy
;
Prospective Studies
;
Quality Assurance, Health Care
;
Signal-To-Noise Ratio
;
Veins*